中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2015年
18期
55-57
,共3页
慢性肺源性心脏病合并心力衰竭%比索洛尔%临床疗效
慢性肺源性心髒病閤併心力衰竭%比索洛爾%臨床療效
만성폐원성심장병합병심력쇠갈%비색락이%림상료효
Chronic pulmonary heart disease with heart failure%Bisoprolol%Clinical efficacy
目的 探讨比索洛尔治疗慢性肺源性心脏病合并心力衰竭的临床疗效.方法 对照组慢性肺源性心脏病合并心力衰竭患者给予临床常规治疗,研究组在常规治疗的基础上加用比索洛尔,两组均持续治疗12周,记录其临床疗效并给予统计学分析后得出结论.结果 研究组临床治疗总有效率高达91.11%,显著高于对照组的73.33%,差异有统计学意义(P<0.05).结论 在常规治疗基础上加用比索洛尔可显著提高慢性肺源性心脏病合并心力衰竭患者的临床疗效,有效保障其生活质量及生命安全.
目的 探討比索洛爾治療慢性肺源性心髒病閤併心力衰竭的臨床療效.方法 對照組慢性肺源性心髒病閤併心力衰竭患者給予臨床常規治療,研究組在常規治療的基礎上加用比索洛爾,兩組均持續治療12週,記錄其臨床療效併給予統計學分析後得齣結論.結果 研究組臨床治療總有效率高達91.11%,顯著高于對照組的73.33%,差異有統計學意義(P<0.05).結論 在常規治療基礎上加用比索洛爾可顯著提高慢性肺源性心髒病閤併心力衰竭患者的臨床療效,有效保障其生活質量及生命安全.
목적 탐토비색락이치료만성폐원성심장병합병심력쇠갈적림상료효.방법 대조조만성폐원성심장병합병심력쇠갈환자급여림상상규치료,연구조재상규치료적기출상가용비색락이,량조균지속치료12주,기록기림상료효병급여통계학분석후득출결론.결과 연구조림상치료총유효솔고체91.11%,현저고우대조조적73.33%,차이유통계학의의(P<0.05).결론 재상규치료기출상가용비색락이가현저제고만성폐원성심장병합병심력쇠갈환자적림상료효,유효보장기생활질량급생명안전.
Objective To investigate the clinical effect of bisoprolol on chronic pulmonary heart disease complicated with heart failure.Methods The control group was given clinical routine treatment,the study group was given bisoprolol in addition of conventional therapy,the patients were treated for 12 weeks.The clinical effects were recorded.Results The total efficiency rate in study group was 91.11%,which was significantly higher than the total efficiency of the coutrol group (73.33%),there was significant difference (P <0.05).Conclusions Based on conventional therapy,the use of bisoprolol can significantly improve the clinical efficacy of chronic pulmonary heart disease in patients with heart failure,effectively guarantee their quality of life and safety.